Sorriso Pharmaceuticals, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Sorriso Pharmaceuticals, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06080048
- Locations
- 🇺🇦
Arensia Exploratory Medicine, Kyiv, Ukraine
News
No news found